A Schmidt1, M Bloechinger2, A Weber1, J Siveke1, S von Delius1, C Prinz3, W Schmitt2, R M Schmid2, B Neu1. 1. II. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. 2. Klinikum München-Neuperlach, Städtisches Klinikum München GmbH, Munich, Germany. 3. Medizinische Klinik 2, Helios Klinikum Wuppertal, Germany.
Abstract
BACKGROUND AND STUDY AIMS: Radiofrequency ablation (RFA) is a new endoscopic palliation therapy for malignant biliary obstruction. The aim of this study was to compare the short-term effects of biliary drainage and adverse events of this technique with the standard of endoscopical treatment of hilar cholangiocarcinoma, photodynamic therapy (PDT). PATIENTS AND METHODS: We retrospectively and since December 2012 prospectively investigated the efficacy and adverse events of RFA in patients with hilar cholangiocarcinoma in two tertiary referral centers between November 2011 and January 2013. The approach of the study was prospective, but because of the large amount of retrospectively included patients, the design of the study is overall retrospective. A group of 20 patients treated with PDT between April 2005 and May 2011 served as a historical control. RESULTS: Fourteen patients received 31 biliary RFAs and 20 patients received 36 PDTs. Within the RFA group, a significant decrease (p = 0.046) of the bilirubin level was seen 14 days after the first RFA (3.3 ± 3.9 (mg/dl) versus 2.3 ± 2.6 (mg/dl)). In the PDT group no significant decrease (p = 0.67) of the bilirubin level was obtained (4.1 ± 6.9 (mg/dl) versus 3.5 ± 5.3 (mg/dl)). In the PDT group (13/20, 65%) a significantly higher number of premature stent replacements (<3 months) after the first intervention was noticed in comparison with the RFA group (four of 14, 29%) (p < 0.01). Between the first and fifth procedure, post-interventional adverse events tend to occur more frequently in patients with PDT (eight of 20, 40%) than with RFA (three of 14, 21%) (p = 0.277). CONCLUSIONS: Looking at the short-term effects, we conclude that RFA may present a therapeutic alternative to PDT for palliative treatment of malignant biliary obstruction because of its simple feasibility and moderate adverse event rate. To provide a definitive evaluation of the long-term effects and of overall median survival, a controlled trial with PDT must follow.
BACKGROUND AND STUDY AIMS: Radiofrequency ablation (RFA) is a new endoscopic palliation therapy for malignant biliary obstruction. The aim of this study was to compare the short-term effects of biliary drainage and adverse events of this technique with the standard of endoscopical treatment of hilar cholangiocarcinoma, photodynamic therapy (PDT). PATIENTS AND METHODS: We retrospectively and since December 2012 prospectively investigated the efficacy and adverse events of RFA in patients with hilar cholangiocarcinoma in two tertiary referral centers between November 2011 and January 2013. The approach of the study was prospective, but because of the large amount of retrospectively included patients, the design of the study is overall retrospective. A group of 20 patients treated with PDT between April 2005 and May 2011 served as a historical control. RESULTS: Fourteen patients received 31 biliary RFAs and 20 patients received 36 PDTs. Within the RFA group, a significant decrease (p = 0.046) of the bilirubin level was seen 14 days after the first RFA (3.3 ± 3.9 (mg/dl) versus 2.3 ± 2.6 (mg/dl)). In the PDT group no significant decrease (p = 0.67) of the bilirubin level was obtained (4.1 ± 6.9 (mg/dl) versus 3.5 ± 5.3 (mg/dl)). In the PDT group (13/20, 65%) a significantly higher number of premature stent replacements (<3 months) after the first intervention was noticed in comparison with the RFA group (four of 14, 29%) (p < 0.01). Between the first and fifth procedure, post-interventional adverse events tend to occur more frequently in patients with PDT (eight of 20, 40%) than with RFA (three of 14, 21%) (p = 0.277). CONCLUSIONS: Looking at the short-term effects, we conclude that RFA may present a therapeutic alternative to PDT for palliative treatment of malignant biliary obstruction because of its simple feasibility and moderate adverse event rate. To provide a definitive evaluation of the long-term effects and of overall median survival, a controlled trial with PDT must follow.
Authors: Helmut Witzigmann; Frieder Berr; Ulrike Ringel; Karel Caca; Dirk Uhlmann; Konrad Schoppmeyer; Andrea Tannapfel; Christian Wittekind; Joachim Mossner; Johann Hauss; Marcus Wiedmann Journal: Ann Surg Date: 2006-08 Impact factor: 12.969
Authors: Bret T Petersen; Ram Chuttani; Joseph Croffie; James DiSario; Julia Liu; Daniel Mishkin; Raj Shah; Lehel Somogyi; William Tierney; Louis M Wong Kee Song Journal: Gastrointest Endosc Date: 2006-06 Impact factor: 9.427
Authors: Andrea Oliver Tal; Johannes Vermehren; Mireen Friedrich-Rust; Jörg Bojunga; Christoph Sarrazin; Stefan Zeuzem; Jörg Trojan; Jörg Gerhard Albert Journal: World J Gastrointest Endosc Date: 2014-01-16
Authors: Werner Dolak; Florian Schreiber; Hubert Schwaighofer; Michael Gschwantler; Wolfgang Plieschnegger; Alexander Ziachehabi; Andreas Mayer; Ludwig Kramer; Andreas Kopecky; Christiane Schrutka-Kölbl; Gernot Wolkersdörfer; Christian Madl; Frieder Berr; Michael Trauner; Andreas Püspök Journal: Surg Endosc Date: 2013-10-03 Impact factor: 4.584
Authors: Pim B Olthof; Robert J Coelen; Michal Heger; Heinz-Josef Klümpen; Erik A Rauws; Thomas M van Gulik Journal: United European Gastroenterol J Date: 2017-01-12 Impact factor: 4.623
Authors: Udayakumar Navaneethan; Nirav Thosani; Adam Goodman; Michael Manfredi; Rahul Pannala; Mansour A Parsi; Zachary L Smith; Shelby A Sullivan; Subhas Banerjee; John T Maple Journal: VideoGIE Date: 2017-09-28
Authors: Vítor Ottoboni Brunaldi; José Eduardo Brunaldi; José Dirceu Vollet-Filho; Mariangela Ottoboni Brunaldi; José Celso Ardengh; Vanderlei Salvador Bagnato; José Sebastião Dos-Santos; Rafael Kemp Journal: Arq Bras Cir Dig Date: 2020-11-13